The independent source for health policy research, polling, and news.
2,661-2,680 of 4,036 results
The legislation, passed by the House, would allow nationwide “association health plans.” But consumer advocates have raised serious concerns about such options in the past.
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP’s plan for repealing and replacing Obamacare.
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
Not being officially admitted — a status known as observation care — can have financial consequences for beneficiaries, and patients had often complained they were not informed.
A Kaiser Permanente pain management program in Southern California aims to help patients taper off addictive painkillers. Some doctors and patients see it as a godsend; others complain that patients have been cut off medications they need.
Blue Shield of California is hoping to steer consumers to "preferred" pharmacies where drugs are cheaper and copays lower.
An electronic consulting and referral system adopted by the county’s safety net public health system in 2012 has reduced waiting times for appointments with specialists and eliminated the need for such appointments in a significant number of cases, according to a new study in the journal Health Affairs.
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.
Although Republicans flirted with the idea of changing the tax code so that the value of employer-sponsored health insurance is added to workers’ tax liability, House leaders decided to instead keep the ACA’s tax on insurers and employers that provide generous coverage.
After the medical board reinstated the license of doctor who molested patients, one member –now president -- secured a $40 million donation for a pet project from the doctor’s relative. He says the two events are unrelated. Critics are demanding an investigation.
© 2026 KFF